1. A composition comprising vancomycin, DCP liposomes and / or liposomes DMPG.2. The composition of claim 1 comprising vancomycin, DSPC, DCP and holesterin.3. A composition according to claim 2, characterized in that the DSPC, DCP and cholesterol are in a molar ratio of 7: 2: 1.4. The composition of claim 1 comprising vancomycin, DSPC, DMPG and holesterin.5. A composition according to claim 4, characterized in that the DSPC, DMPG are in a molar ratio of 7: 2: 1.6. A method of treating infection in a human comprising: - providing a composition comprising vancomycin, DCP liposomes and / or liposomes DMPG u administering a therapeutically effective amount of a composition to a human to treat infektsiyu.7. A method according to claim 6, characterized in that the composition contains vancomycin, DSPC, DCP and holesterin.8. A method according to claim 7, characterized in that the DSPC, DCP and cholesterol are in a molar ratio of 7: 2: 1.9. A method according to claim 6, characterized in that the composition comprises DSPC, DMPG and holesterin.10. A method according to claim 9, characterized in that the DSPC, DMPG are in a molar ratio of 7: 2: 1.11. A method according to claim 6, wherein the infection is a bacterial infection caused by a microorganism selected from the group consisting of: Staphylococcus aureus (S. aureus), Methicillin-resistant S. aureus, Staphylococcus aureus, having the intermediate susceptibility to vancomycin, S . pneumoniae, E. faecalis, E. faecium, coagulase-negative staphylococci and kombinatsiy.12. A method according to claim 6, wherein the infection is caused by methicillin-resistant S. aureus.13. Kit for treating a bacterial infection comprising: - composition containing vancomycin, DCP liposomes and / or liposomes DMPG u instructions for their use for the treatment of a bacterial infection in cheloveka.14. A kit according to claim 13, characterized in that the composition comprises vankomits1. Композиция, содержащая ванкомицин, липосомы DCP и/и
